Peter Kamenický

28PUBLICATIONS
127CO-AUTHORS
Photonics, optoelectronics and optical communicationsGenome structure and regulationInfant and child healthPacific Peoples and disabilityToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 23, 2026
Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia.

|Jun 17, 2026
The renin-angiotensin system is activated by short-term, but repressed by long-term growth hormone excess.

|May 20, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

|Apr 27, 2026
Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry.

|Apr 15, 2026
Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

|Dec 24, 2025
Continuous subcutaneous administration of teriparatide as a therapeutic option in chronic hypoparathyroidism: retrospective study in three tertiary care centers of the epi-hypo study.

Amina Attia, Mathilde Brière, Peter Kamenicky

Pageof 5

Frequent Collaborators

6 joint publications

Peter Wolf

6 joint publications

Philippe Chanson

6 joint publications

Karine Briot

5 joint publications

Agnès Linglart